With the increase in viable sampling frequency, more sterile compounding facilities are taking sample collection, incubation, and analysis in-house. This is a major undertaking that requires knowledgeable, dedicated staff to ensure not only compliance with USP General Chapter <797>, but also the incorporation of microbiological best practices that are not addressed in the chapter. This presentation will address 5 common errors that sterile compounding facilities make when taking on viable sampling and incubation.
Learning Objectives:
- Identify potential shortcomings in your sterile compounding facility's viable sampling program.
- Discuss changes that can be made to the viable sampling program to ensure compliance.
- List industry standards and guides that aid in the development of a robust viable sampling program.